Analysts Set Expectations for AMERISAFE FY2026 Earnings

Key Points

• DOWLING & PARTN cut its FY2026 EPS forecast for AMERISAFE to $1.95 from $2.05, still slightly above the analyst consensus of $1.92. It projected EPS of $1.90 for FY2027 and $1.70 for FY2028.
• AMERISAFE’s latest quarterly results missed expectations: EPS was $0.40 versus the $0.48 consensus, while revenue of $79.81 million fell short of the $84.72 million estimate. Analysts’ overall rating was Hold, with a consensus price target of $33.33.
• The company announced a quarterly dividend of $0.41 per share, equivalent to $1.64 annually and an indicated yield of 8.1%.

AMERISAFE, Inc. (NASDAQ:AMSF - Free Report) - DOWLING & PARTN dropped their FY2026 earnings estimates for shares of AMERISAFE in a report released on Wednesday, November 4th. DOWLING & PARTN analyst P. Christensen now expects that the insurance provider will post earnings per share of $1.95 for the year, down from their prior estimate of $2.05. The consensus estimate for AMERISAFE's current full-year earnings is $1.92 per share. DOWLING & PARTN also issued estimates for AMERISAFE's FY2027 earnings at $1.90 EPS and FY2028 earnings at $1.70 EPS.

Other equities analysts have also recently issued research reports about the company. Wall Street Zen raised AMERISAFE from a "sell" rating to a "hold" rating in a research note on Saturday, October 31st. Morgan Stanley set a $40.00 price target on shares of AMERISAFE in a research report on Monday, October 12th. Zacks Research upgraded shares of AMERISAFE from a "strong sell" rating to a "hold" rating in a report on Monday, September 28th. Citigroup reaffirmed a "market outperform" rating on shares of AMERISAFE in a research report on Monday, October 12th. Finally, Citizens Jmp lowered their price objective on shares of AMERISAFE from $40.00 to $35.00 and set a "market outperform" rating on the stock in a research report on Thursday, October 29th. Two equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company's stock. According to MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $33.33.

AMERISAFE Trading Down 0.7%

NASDAQ:AMSF opened at $20.34 on Thursday. The firm has a market capitalization of $376.96 million, a price-to-earnings ratio of 9.46 and a beta of 0.23. AMERISAFE has a 1-year low of $20.13 and a 1-year high of $42.10. The business's fifty day moving average price is $24.56 and its 200 day moving average price is $30.72.

AMERISAFE (NASDAQ:AMSF - Get Free Report) last announced its earnings results on Wednesday, October 28th. The insurance provider reported $0.40 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.48 by ($0.08). The firm had revenue of $79.81 million for the quarter, compared to analyst estimates of $84.72 million. AMERISAFE had a net margin of 12.10% and a return on equity of 14.15%.

AMERISAFE Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, December 11th. Shareholders of record on Friday, December 4th will be given a $0.41 dividend. This represents a $1.64 annualized dividend and a yield of 8.1%. The ex-dividend date of this dividend is Friday, December 4th. AMERISAFE's dividend payout ratio is presently 76.28%.

Institutional Investors Weigh In On AMERISAFE

A number of hedge funds and other institutional investors have recently made changes to their positions in AMSF. Parallel Advisors LLC increased its stake in shares of AMERISAFE by 1,405.0% during the 3rd quarter. Parallel Advisors LLC now owns 2,709 shares of the insurance provider's stock worth $64,000 after purchasing an additional 2,529 shares during the last quarter. CenterBook Partners LP bought a new position in AMERISAFE during the third quarter valued at about $477,000. Mirae Asset Global Investments Co. Ltd. acquired a new stake in shares of AMERISAFE in the third quarter worth about $417,000. Isthmus Partners LLC lifted its position in shares of AMERISAFE by 28.1% in the third quarter. Isthmus Partners LLC now owns 136,969 shares of the insurance provider's stock worth $3,237,000 after buying an additional 30,083 shares during the last quarter. Finally, Counterpoint Mutual Funds LLC bought a new stake in shares of AMERISAFE during the 3rd quarter worth about $431,000. 97.41% of the stock is owned by hedge funds and other institutional investors.

AMERISAFE Company Profile

AMERISAFE, Inc is a specialty workers' compensation insurance company serving small and midsized businesses. The company focuses on employers in industries with elevated workplace risks, including construction, trucking, logging, agriculture, manufacturing, and maritime operations.

Through its insurance subsidiaries, AMERISAFE provides workers' compensation coverage designed to protect businesses from costs associated with workplace injuries and occupational illnesses. Its services also include workplace safety and loss-control support, claims management, medical cost containment, and premium audit services.

Headquartered in DeRidder, Louisiana, AMERISAFE primarily serves employers in the southeastern and south-central United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.